Differences in the inhibition of neuritic outgrowth in organotypic cultures of rat foetal dorsal root ganglia treated with cisplatin and carboplatin: A comparative study

Folia Histochemica et Cytobiologica

Volumn 35, Issue 4, 1997, Pages 215-219

  Jirsova K ^a,b   Mandys, V ^a,b,c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF EXPERIMENTAL BOTANY   (Czech Republic)

Author keywords

Carboplatin; Cisplatin; Dorsal root ganglia; Neuritic outgrowth

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FETUS; NERVE FIBER GROWTH; NEUROTOXICITY; NONHUMAN; RAT; SPINAL GANGLION; TISSUE CULTURE;

EID: 0030880980     PISSN: 00155586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bär PR, Mandys V, Tureček R, Gispen WH (1994) α-melano-cyte-stimulating hormone has protective properties against the toxic effect of cisplatin on cultured dorsal root ganglia. Ann Sci 680: 649-651
2. Bishop JF (1995) Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer. Lung-Cancer 12, Suppl 2: S53-61
3. Bonjo CA, Engstrom PF, Litwin S, Ozols, RF (1995) Paclitaxel and carboplatin for the treatment of metastatic breast cancer. J Clin Oncol 13: 1860-1870
4. Gershenson DM, Morris M, Burke TW, Levenback C, Kavanagh JJ, Fromm GL (1995) Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gynecol Oncol 58: 349-55
5. 4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro. J Neurosci Res 39:178-185
6. Haykawa K, Sobue G, Itoh T, Mitsuma T (1994) Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitro. Life Sci 55: 519-525
7. Jirsová K, Mandys V (1996) Carboplatin-induced micronuclei formation in non-neuronal cells of rat foetal dorsal root ganglia cultured in vitro and comparison with another anticancer drug cisplatin. Sborn Lek 397: 331-342
8. Knox RJ, Friedlos F, Lydall DA, Roberts JJ (1986) Mechanism of cytotoxicity of anticancer platinum drugs: Evidence that c/5-Diamminedichloroplatinum(II) and cis-Diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. Cancer Res 46: 1972-1979
9. Konings PNM, Makkink WK, van Delft AML, Ruight GSF (1994) Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro. Brain Res 640: 195-204
10. Langer CJ, Leighton JC, Comis RL, ODwyer, PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF (1995) Paclitaxel by 24-or 1-hour infusion in combination withcarboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Semin Oncol 22: 18-29
11. Mandys V, Tureček V, Gispen WH, Bär PR (1994) Organotypic cultures of chick dorsal root ganglia in a semi-solid medium: A model for neurotoxicity testing. Toxic in Vitro 8: 81-90
12. Micetich KC, Barnes D, Erickson LC (1985) A comparative study of the cytotoxicity and DNA-damaging effects of cis-(Diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-Diamminedichloroplatinum(II)on L1210 cells. Cancer Res 45: 4043-4047
13. Oguri S, Sakakibara T, Mase H, Shimizu T, Ishikawa K, Smyth RD (1988) Clinical pharmacokinetics of carboplatin. J Clin Pharmacol 28: 208-215
14. Overbeck TL, Knight JM, Beck DJ (1996) A comparison of genotoxic effects of carboplatin and cisplatin in Escherichia coli. Mutation Res 362: 249-259
15. Patton JF, Powell BL, White DR, Russell GB, Inabinet RT, Muss HB (1996) Combination cisplatin and carboplatin in advanced sqamous cell carcinoma of the head and neck. Cancer Invest 14: 98-102
16. Silva EG, Warner D, Wharton JT (1995) Combined cisplatin and carboplatin chemotherapy for treatment of ad vanced epithelial ovarian cancer. Gynecol Oncol 58: 349-55
17. Terheggen PMAB, Gerritsen van der Hoop R, Floot BGJ, Gispen WH (1989) Cellular distribution of cis-diamminedichloroplatinum(II)-DNA binding in rat dorsal root spinal ganglia: Effect of the neuroprotecting peptide ORG .2766. Toxicol Appl Pharmacol 99: 334-343
18. Terheggen PMAB, Begg AC, Emondt JY, Dubbelman R, Floot BGJ, den Engelse L (1991) Formation of interaction products of carboplatin with DNA in vitro and in cancer patients. Br J Cancer 63: 195-200
19. Tomiwa K, Nolan C, Cavanagh JB (1986) The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry. Acta Neuropathol (Berl) 69: 295-308
20. Wagstaff AJ, Ward A, Benfield P, Heel RC (1989). Carboplatin: A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs 37: 162-190
21. Yao WQ, Fossa SD, Dearnaley DP, Horwich A (1994) Combined single course carboplatin with radiotherapy in treatment of stage IIA,B seminoma, a report. Radiother Oncol 33: 88-90